Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: Synthesis, cytotoxicity and antitubulin activity

European Journal of Medicinal Chemistry

Volumn 52, Issue , 2012, Pages 22-32

  Rasolofonjatovo, Evelia ^a   Provot, Olivier ^a   Hamze, Abdallah ^a   Rodrigo, Jordi ^a   Bignon, Jérome ^b   Wdzieczak Bakala, Joanna ^b   Desravines, Déborah ^b   Dubois, Joëlle ^b   Brion, Jean Daniel ^a   Alami, Mouad ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b CNRS   (France)

Author keywords

Antimitotic; Combretastatin A 4; Cytotoxicity; isoCA 4; Restricted analogues; Tubulin

Indexed keywords

2 METHOXY 5 (3,4,5 TRIMETHOXYPHENYL) 5,6,7,7 TETRAHYDRONAPHTHALEN 1 OL; 2 METHOXY 5 (3,4,5 TRIMETHOXYPHENYL) 7,8 DIHYDRONAPHTHALEN 1 AMINE; 2 METHOXY 5 (3,4,5 TRIMETHOXYPHENYL) 7,8 DIHYDRONAPHTHALEN 1 OL; 2 METHOXY 5 (3,4,5 TRIMETHOXYPHENYL)NAPHTHALEN 1 AMINE; 5 (3,5 DIMETHOXYPHENYL) 2 METHOXY 7,8 DIHYDRONAPHTHALEN 1 OL; COMBRETASTATIN A4; ISOCOMBRETASTATIN A4 DERIVATIVE; ISOERIANIN DERIVATIVE; NAPHTHALENE DERIVATIVE; TUBULIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANTINEOPLASTIC AGENTS; BENZENE; BIBENZYLS; CELL LINE, TUMOR; CHLOROPHENOLS; HUMANS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; NAPHTHALENES; PEPTIDES, CYCLIC; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; TUBULIN; TUBULIN MODULATORS;

EID: 84860349179     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2012.03.001     Document Type: Article

References (49)

1. A. Jordan, J.A. Hadfield, N.J. Lawrence, and A.T. Mc Gown Med. Res. Rev. 18 1998 259 296
2. T. Beckers, and S. Mahboobi Drug Future 28 2003 767 785
3. J.A. Hadfield, S. Ducki, N. Hirst, and A.T. Mc Gown Prog. Cell Cycle Res. 5 2003 309 325
4. F. Gueritte, and J. Fahy G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer Agents from Natural Products 2005 CRC Press L. Boca Raton 123 135
5. M.A. Jordan, and L. Wilso Nat. Rev. Cancer 4 2004 253 265
6. E.K. Rowinsky, and R.C. Donehower Pharmacol. Ther. 52 1992 35 84
7. R.J. Freilich, C. Balmaceda, A.D. Seidman, M. Rubin, and L.M. DeAngelis Neurology 47 1996 115 118
8. P.H. Hilkens, J. Verweij, C.J. Vecht, G. Stoter, and M.J. van den Bent Ann. Oncol. 8 1997 187 190
9. A.T. Fojo, and M. Menefee Semin. Oncol. 32 2005 S3 S8
10. C. Dumontet, and B.I. Sikic J. Clin. Oncol. 17 1999 1061 1070
11. G.R. Pettit, S.B. Singh, E. Hamel, C.M. Lin, D.S. Alberts, and D. Garcia-Kendall Experientia 45 1989 209 211
12. G.R. Pettit, S.B. Singh, M.R. Boyd, E. Hamel, R.K. Pettit, J.M. Schmidt, and F. Hogan J. Med. Chem. 38 1995 1666 1672
13. G.R. Pettit, M.R. Rhodes, D.L. Herald, E. Hamel, J.M. Schmidt, and R.K. Pettit J. Med. Chem. 48 2005 4087 4099
14. A.T. McGown, and B.W. Fox Cancer Chemother. Pharmacol. 26 1990 79 81
15. J.P. Liou, Y.L. Chang, F.M. Kuo, C.W. Chang, H.Y. Tseng, C.C. Wang, Y.N. Yang, J.Y. Chang, S.J. Lee, and H.P. Hsieh J. Med. Chem. 47 2004 4247 4257
16. G.M. Tozer, V.E. Prise, J. Wilson, R.J. Locke, B. Vojnovic, M.R. Stratford, M.F. Dennis, and D.J. Chaplin Cancer Res. 59 1999 1626 1634
17. G.R. Pettit, C. Temple, V.L. Narayanan, R. Varma, M.J. Simpson, M.R. Boyd, G.A. Rener, and N. Bansal Anticancer Drug Des. 10 1995 299 309
18. D.W. Siemann, D.J. Chaplin, and P.A. Walicke Expert Opin. Investig. Drugs 18 2009 189 197
19. K. Oshumi, R. Nakagawa, Y. Fukuda, T. Hatanaka, and T. Tsuji J. Med. Chem. 41 1998 3022 3032
20. T. Hatanaka, K. Fujita, K. Oshumi, R. Nakagawa, Y. Fukuda, Y. Nihei, Y. Suga, Y. Akiyama, and T. Tsuji Bioorg. Med. Chem. Lett. 8 1998 3371 3374
21. J.W. Lippert Bioorg. Med. Chem. 15 2007 605 615
22. K. Ohsumi, T. Hatanaka, K. Fujita, R. Nakagawa, Y. Fukuda, Y. Nihei, Y. Suga, Y. Morinaga, Y. Akiyama, and T. Tsuji Bioorg. Med. Chem. Lett. 8 1998 3153 3158
23. S. Aprile, E. Del Grosso, G.C. Tron, and G. Grosa Drug Metab. Dispos. 35 2007 2252 2261
24. C. Mousset, A. Giraud, O. Provot, A. Hamze, J. Bignon, J.-M. Liu, S. Thoret, J. Dubois, J.-D. Brion, and M. Alami Bioorg. Med. Chem. Lett. 18 2008 3266 3271
25. E. Rasolofonjatovo, O. Provot, A. Hamze, J. Bignon, S. Thoret, J.-D. Brion, and M. Alami Eur. J. Med. Chem. 45 2010 3617 3626
26. O. Provot, A. Giraud, J.-F. Peyrat, M. Alami, and J.-D. Brion Tetrahedron Lett. 46 2005 8547 8550
27. C. Mousset, O. Provot, A. Hamze, J. Bignon, J.-D. Brion, and M. Alami Tetrahedron 64 2008 4287 4294
28. N. L'Hermite, A. Giraud, O. Provot, J.-F. Peyrat, M. Alami, and J.-D. Brion Tetrahedron 62 2006 11994 12002
29. A. Giraud, O. Provot, J.-F. Peyrat, M. Alami, and J.-D. Brion Tetrahedron 62 2006 7667 7673
30. S. Messaoudi, B. Tréguier, A. Hamze, O. Provot, J.-F. Peyrat, J.R. Rodrigo De Losada, J.-M. Liu, J. Bignon, J. Wdzieczak-Bakala, S. Thoret, J. Dubois, J.-D. Brion, and M. Alami J. Med. Chem. 52 2009 4538 4542
31. A. Hamze, D. Veau, O. Provot, J.-D. Brion, and M. Alami J. Org. Chem. 74 2009 1337 1340
32. E. Rasolofonjatovo, B. Tréguier, O. Provot, H. Hamze, E. Morvan, J.-D. Brion, and M. Alami Tetrahedron Lett. 52 2011 1036 1040
33. E. Brachet, A. Hamze, J.-F. Peyrat, Jean-Daniel Brion, and M. Alami Org. Lett. 12 2011 4042 4045
34. M.A. Soussi, S. Aprile, S. Messaoudi, O. Provot, E. Del Grosso, J. Bignon, J. Dubois, J.-D. Brion, G. Grosa, and M. Alami ChemMedChem 6 2011 1781 1788
35. A. Hamze, A. Giraud, S. Messaoudi, O. Provot, J.-F. Peyrat, J. Bignon, J.-M. Liu, J. Wdzieczak-Bakala, S. Thoret, J. Dubois, J.-D. Brion, and M. Alami ChemMedChem 4 2009 1912 1924
36. A. Hamze, E. Rasolofonjatovo, O. Provot, C. Mousset, D. Veau, J. Rodrigo, J. Bignon, J.-M. Liu, J. Wdzieczak-Bakala, S. Thoret, J. Dubois, J.-D. Brion, and M. Alami ChemMedChem 6 2011 2179 2191
37. S. Messaoudi, A. Hamze, O. Provot, B. Tréguier, J. Rodrigo De Losada, J. Bignon, J.-M. Liu, J. Wdzieczak-Bakala, S. Thoret, J. Dubois, J.-D. Brion, and M. Alami ChemMedChem 6 2011 488 497
38. R.B. Ravelli, B. Gigant, P.A. Curmi, I. Jourdain, S. Lachkar, A. Sobel, and M. Knossow Nature 428 2004 198 202
39. F. Lara-Otchoa, and G. Espinosa-Perez Tetrahedron Lett. 48 2007 7007 7010
40. I. Pravst, M. Zupan, and S. Stavber Tetrahedron Lett. 47 2006 4707 4710
41. B. Tréguier, A. Hamze, O. Provot, J.-D. Brion, and M. Alami Tetrahedron Lett. 50 2009 6549 6552
42. J. Barluenga, P. Morel, C. Valdés, and F. Aznar Angew. Chem. Int. Ed. 46 2007 5587 5590
43. S. Messaoudi, J.-D. Brion, and M. Alami Adv. Synth. Catal. 352 2010 1677 1687
44. S. Messaoudi, J.-D. Brion, and M. Alami Mini-Rev. Org. Chem. 8 2011 448 454
45. K. Anderson, T. Ikawa, R.E. Tundel, and S.L. Buchwald J. Am. Chem. Soc. 128 2006 10694 10695
46. M. Alami, F. Ferri, and G. Linstrumelle Tetrahedron Lett. 34 1993 6403 6407
47. A. Giraud, O. Provot, A. Hamze, J.-D. Brion, and M. Alami Tetrahedron Lett. 49 2008 1107 1110
48. K.G. Pinney, V.P. Mocharla, Z. Chen, C.M. Garner, A. Ghatak, M. Hadimani, J. Kessler, J.M. Dorsey, K. Edvardsen, D.J. Chaplin, J. Prezioso, U.R. Ghatak, U.S. Patent Appl. Publ. (2004) 20040043969 A1.
49. D.M. Barron, S.K. Chatterjee, R. Ravindra, R. Roof, E. Baloglu, D.G.I. Kingston, and S. Bane Anal. Biochem. 315 2003 49 56